Synthon Pharmaceuticals Enters Into Global License Agreement With Amgen (AMGN) and Watson Pharmaceuticals, Inc. (WPI) for Biosimilar Trastuzumab
7/18/2012 9:18:09 AM
More...
|
Synthon Pharmaceuticals Appoints Paul Roos as Chief Financial Officer
5/7/2012 10:20:40 AM
More...
|
Synthon Pharmaceuticals Successfully Concluded Phase I Clinical Trial for Trastuzumab
3/22/2012 1:30:10 PM
More...
|
Perrigo Company (PRGO) and its Partner Synthon Pharmaceuticals Launch Levocetirizine Solution - Generic Equivalent to Xyzal(R) Oral Solution
11/8/2011 6:02:57 AM
More...
|
Perrigo Co. (PRGO)'s Partner Synthon Pharmaceuticals Receives FDA Tentative Approval for Levocetirizine Solution - Generic Equivalent to Xyzal(R) Oral Solution
5/18/2011 9:01:45 AM
More...
|
Breckenridge Pharmaceutical, Inc. and Synthon Pharmaceuticals Announces Settlement of Actos(R) (Pioglitazone Hydrochloride) Patent Litigation With Takeda Pharmaceutical Co. Ltd. (TKDG.DE)
5/16/2011 9:58:13 AM
More...
|
Perrigo Company (PRGO) Confirms That its Partner Synthon Pharmaceuticals Has Filed for Generic Version of Xyzal(R)
6/24/2009 10:34:29 AM
More...
|
Perrigo Company (PRGO) Acquires Exclusive Sales and Distribution Rights to Allergy Drug Levocetirizine from Synthon Pharmaceuticals
9/8/2008 6:49:58 AM
More...
|
Pfizer Inc. (PFE) Wins Norvasc Patent Challenge By Generic Manufacturer Synthon Pharmaceuticals
9/1/2006 10:09:06 AM
More...
|
JDS Pharmaceuticals And Synthon Pharmaceuticals Enter Co-Promotion For LITHOBID(R)
10/19/2005 5:12:38 PM
More...
|
|